The protective role of NF-κB and AP-1 in arsenite-induced apoptosis in aortic endothelial cells

被引:25
作者
Tsou, TC [1 ]
Tsai, FY [1 ]
Wu, MC [1 ]
Chang, LW [1 ]
机构
[1] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Kaohsiung 807, Taiwan
关键词
arsenite; apoptosis; aortic endothelial cells; NF-kappa B; AP-1;
D O I
10.1016/S0041-008X(03)00239-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Arsenite (NaAsO2) has been shown to produce vascular dysfunction in many studies. Arsenite-induced damage to vascular endothelial cells represents one of the possible mechanisms causing leakage of the vascular endothelial barrier. To explore arsenite-induced vascular endothelial damage, we used primary porcine aortic endothelial cells (PAECs) as an in vitro system to test the effects of arsenite on signal transduction pathways and apoptosis. Here we demonstrated that arsenite exposure induced apoptosis accompanied by the occurrence of apoptotic signals including degradation of poly(ADP-ribose) polymerase (PARP) and CPP32 (cleavage/activation) and DNA ladder formation. By using the luciferase reporter assay, we demonstrated that arsenite exposure differentially activated two redox-sensitive transcription factors, NF-kappaB and AP-1. Lower levels of arsenite exposure (25 muM NaAsO2, 24 h) induced co-activation of NF-kappaB and AP-1, accompanied by 9% total apoptosis. In contrast, higher levels of arsenite exposure (40 muM NaAsO2, 24 h) induced higher levels of AP-1 activation, accompanied by 45% total apoptosis. Blockade of NF-kappaB or JNK activity further enhanced arsenite-induced apoptosis. Upregulation of JNK activity showed no effect on arsenite-induced apoptosis. Based on these data, we propose that activation of redox-sensitive transcription factors, NF-kappaB and AP-1, plays a very important role in the protection of PAECs from arsenite-induced apoptosis. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:177 / 187
页数:11
相关论文
共 68 条
[1]  
[Anonymous], MOL CLONING
[2]   Okadaic acid and anisomycin are protective and stimulate the SAP/JNK pathway [J].
Barancik, M ;
Htun, P ;
Schaper, W .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1999, 34 (02) :182-190
[3]   Low levels of arsenic trioxide stimulate proliferative signals in primary vascular cells without activating stress effector pathways [J].
Barchowsky, A ;
Roussel, RR ;
Klei, LR ;
James, PE ;
Ganju, N ;
Smith, KR ;
Dudek, EJ .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1999, 159 (01) :65-75
[4]   Arsenic induces oxidant stress and NF-kappa B activation in cultured aortic endothelial cells [J].
Barchowsky, A ;
Dudek, EJ ;
Treadwell, MD ;
Wetterharn, KE .
FREE RADICAL BIOLOGY AND MEDICINE, 1996, 21 (06) :783-790
[5]   Oxidative DNA adducts and DNA-protein cross-links are the major DNA lesions induced by arsenite [J].
Bau, DT ;
Wang, TS ;
Chung, CH ;
Wang, ASS ;
Jan, KY .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2002, 110 :753-756
[6]   The selective protein kinase C inhibitor, Ro-31-8220, inhibits mitogen-activated protein kinase phosphatase-1 (MKP-1) expression, induces c-Jun expression, and activates Jun N-terminal kinase [J].
Beltman, J ;
McCormick, F ;
Cook, SJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (43) :27018-27024
[7]   SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase [J].
Bennett, BL ;
Sasaki, DT ;
Murray, BW ;
O'Leary, EC ;
Sakata, ST ;
Xu, WM ;
Leisten, JC ;
Motiwala, A ;
Pierce, S ;
Satoh, Y ;
Bhagwat, SS ;
Manning, AM ;
Anderson, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13681-13686
[8]  
Carmignani M, 1985, Arch Toxicol Suppl, V8, P452
[9]   The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase [J].
Cavigelli, M ;
Li, WW ;
Lin, AN ;
Su, B ;
Yoshioka, K ;
Karin, M .
EMBO JOURNAL, 1996, 15 (22) :6269-6279
[10]   The inhibitory action of sodium arsenite on lipopolysaccharide-induced nitric oxide production in RAW 267.4 macrophage cells: A role of Raf-1 in lipopolysaccharide signaling [J].
Chakravortty, D ;
Kato, Y ;
Sugiyama, T ;
Koide, N ;
Mu, MM ;
Yoshida, T ;
Yokochi, T .
JOURNAL OF IMMUNOLOGY, 2001, 166 (03) :2011-2017